Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone

Psychopharmacology (Berl)
July 2010
https://pubmed.ncbi.nlm.nih.gov/20386884/

Rationale: Prescription opioid abuse has risen dramatically in the United States as clinicians have increased opioid prescribing for alleviation of both acute and chronic pain. Opioid analgesics with decreased risk for abuse are needed.

Monica - US: Relapsing Polychondritis (LDN, low dose naltrexone)

An LDN Research Trust Radio show with Linda Elsegood and Monika from the US she talks about her experience of LDN (Low Dose Naltrexone for Relapsing Polychondritis with is a rare condition.

Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)

BMJ Open
06 Jan 2022
https://pubmed.ncbi.nlm.nih.gov/34992118/

Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Can low-dose naltrexone relieve pain?

The Seattle times
12 Jan 2022
https://www.seattletimes.com/life/wellness/can-low-dose-naltrexone-relieve-pain/

At low doses (1 to 4.5 mg) it is prescribed to ease the pain and inflammation associated with conditions such as fibromyalgia, chronic pain syndrome, multiple sclerosis and Crohn’s disease

Low-dose Naltrexone for atopic dermatitis?

National Eczema Association
11 April 2019
https://nationaleczema.org/naltrexone/